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Abstract: During the last 25 years, more than 100,000 patients have been treated with Deep Brain
Stimulation (DBS). While human clinical and animal preclinical research has shed light on the complex
brain-signaling disturbances that underpin e.g., Parkinson’s disease (PD), less information is available
when it comes to complex psychosocial changes following DBS interventions. In this contribution, we
propose to more thoroughly investigate complex personality-related changes following deep brain
stimulation through refined and reliable instruments in order to help patients and their relatives in the
post-surgery phase. By pursuing this goal, we first outline the clinical importance DBS has attained
followed by discussing problematic and undesired non-motor problems that accompany some DBS
interventions. After providing a brief definition of complex changes, we move on by outlining the
measurement problem complex changes relating to non-motor symptoms currently are associated
with. The latter circumstance substantiates the need for refined instruments that are able to validly
assess personality-related changes. After providing a brief paragraph with regard to conceptions
of personality, we argue that the latter is significantly influenced by certain competencies which
themselves currently play only a tangential role in the clinical DBS-discourse. Increasing awareness
of the latter circumstance is crucial in the context of DBS because it could illuminate a link between
competencies and the emergence of personality-related changes, such as new-onset impulse control
disorders that have relevance for patients and their relatives. Finally, we elaborate on the field of
application of instruments that are able to measure personality-related changes.
Keywords: deep brain stimulation; personality; instruments; competencies
1. Introduction
Deep Brain Stimulation (DBS) is a neurosurgical intervention that involves electrode implantation
to apply electrical currents to target structures aiming at alleviating symptoms. More precisely, the
surgical method involves a stereotactical implantation of usually quadripolar electrodes including an
extracerebral “pacemaker” that modulates the activity of selected regions in the brain with electric
impulses. The key advantages of this procedure are (1) its potential reversibility and (2) the possibility
to postoperatively optimize treatment effects via an external programming device. So far, a great
number of patients suffering from various neurological and neuropsychiatric disorders have been
treated with DBS. DBS unquestionably is a remarkable therapy that has provided hope for many
patients and that has been shown to be more effective than best medical treatment for some disorders.
Among those, patients suffering from Parkinson’s disease (PD) and who are refractory to drug
treatment represent by far the largest patient group.
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In the meantime, the rapid development reached a non-undisputed broadening of the therapeutic
spectrum [1]. DBS of the subthalamic nucleus (STN) has been established in randomized, controlled
trials as an effective therapy for the motor symptoms of PD [2–4] and, consequently, the number of
patients being treated by DBS has steadily increased. Along this increase, challenges arose with regard
to appropriate patient selection and side-effects, to name a few. With some delay, the systematic
investigation of neuropsychiatric changes observed in patients treated with DBS for movement
disorders found their way into the scientific literature, first as anecdotal reports and later in the
form of quantitative research studies [5].
In sum, DBS has demonstrated dramatic symptom relief for a multitude of patients. However,
complex non-motor changes following DBS interventions have been described. Because there is only
a very limited number of instruments that are able to validly measure complex personality-related
changes, there is great need for the development of new and reliable instruments in order to collect
information and to evaluate these changes. As will be seen, there is a need to more thoroughly explore
e.g., morally relevant behaviours (such as impulse control disorders, ICDs) with a particular emphasis
on psychosocial competencies. The underlying competencies that might be dysfunctional secondary to
disease, pharmacological therapy or neuromodulation interventions aiming to treat patients suffering
from diseases, however, are hardly the focus of current DBS-research. In turn, new instruments that
are able to quantify and depict such competencies might be highly relevant because they can yield
explanatory power regarding psychosocial changes that are decisive for patients and their relatives.
2. Complex Changes after DBS Interventions
2.1. Non-Motor Problems Following DBS in Movement Disorders
In what will follow and for the sake of clarity, we restrict the argumentation of this contribution
to the context of movement disorders and especially PD, even though we are aware of the fact that
strictly speaking, PD has a well-documented neuropsychiatric impact on patients. Because STN-DBS
in PD is, apart from stimulation of the globus pallidus internus (GPi), most frequently performed, the
argumentation below takes up studies that investigated basal-ganglia dysfunction. Furthermore, a
recent study provides Class II evidence that STN DBS offers more off-phase motor improvement than
GPi DBS with similar risk for behavioural, affective and cognitive complications [6].
Whilst DBS aims primarily at improving motor symptoms in PD, accumulating knowledge points
toward non-motor complications. Because a large number of fibers converge in the basal ganglia nuclei
on a very small area, it is not surprising that targeting specific functions and manipulating them in an
isolated fashion is tremendously difficult. In fact, intervening into basal ganglia physiology bears the
risk of modulating non-motor functions [7–9]. The difficulty of specific targeting is even greater when
factoring in recent notions of re-entrant or interconnected cortico-striato-pallido-thalamo-cortical loops
representing different frequencies [10]. In fact, by manipulating a specific node in the network, one
might influence as many different functions, depending on the degree of shared functionality with
other circuits. Hence, DBS intervenes with a very complex network [11], the shear complexity of which
has probably only started to be deciphered.
A large body of evidence implicates the role of the basal ganglia (BG) in the processing of
non-motor signals and several psychiatric disorders such as schizophrenia, obsessive compulsive
disorder (OCD), phobias and panic attacks, depressive states, addiction and eating disorders [12–14].
Similarly, neuropsychological changes in humans following DBS interventions have been observed [15],
denoting the characterization of the BG as centers of convergence encoding motor, cognitive, associative
and affective processes. Notably, the STN, one of the most commonly targeted structures for DBS in PD,
has a strategic position due to its connections to both BG output structures (the GPi and substantia nigra
pars reticulata (SNr)). Unsurprisingly, modulation of STN-signaling has therefore demonstrated to
result in impulsive responding and dysfunctional inhibitory control, such as perseveration, obsessions
and compulsions [16]. Hence, it is very well possible that interference with basal ganglia nuclei and
the STN specifically, by disease or interventions, can modulate associative and limbic processing.
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Notably, interventions not only include DBS but also e.g., pharmacological treatment. The latter has
demonstrated the potential of causing unintended side-effects either in combination with DBS or
by itself e.g., when drugs are reduced too promptly after DBS initiation or in case of dopamine
agonists [17]. In addition, the dopamine agonist withdrawal syndrome (DAWS) and dopamine
dysregulation syndrome (DDS) leading to neuropsychiatric symptoms and decreased self-control,
respectively, have been described in PD. Therefore, it is widely appreciated that pathological processes
and pharmacological treatment alike can lead to alterations in the processing of emotional, cognitive
and behavioural stimuli [18].
More generally, a number of behavioural and affective sequelae, such as hypomania, new onset
impulse control disorders (ICDs including hypersexuality, pathological buying, pathological gambling,
and addiction to levodopa), logorrhea, irritability, impatience and aggression, distractibility and
attention problems, egocentrism, obstinacy, and lying have been described following DBS treatment
in humans [15,16,19,20]. In the meanwhile, there is also evidence for changes that can be evaluated
positively such as increased emotional wellbeing that results in increased Quality of Life (QoL)
(see Section 2.2).
Undisputedly, complex non-motor changes have been described following DBS. In this
contribution, we extend the topic of non-motor problems and deliberate on complex, non-motor
changes for which the evaluation is unclear (i.e., such changes are not per se problematic and can
even be positively evaluated). Patients who experience substantial symptom relief may develop new
interests and behave differently. While the evaluation of whether these changes are problematic
is important, we may first have to make sure that complex changes can reliably be measured.
This includes the possibility that strictly differentiating between the measurement and evaluation
process is eventually not possible, in particular when measuring personality changes where a positive
or negative evaluation could be intrinsic to the measurement process. Nevertheless, and as will be seen,
sensitive instruments are highly needed. First, however, we will investigate the nature of complex
changes and the fundamental problem they are associated with.
2.2. Complex Changes: In Search of Reliable Instruments
Complex changes can be described as side-effects characterized by two gradual, qualitatively
described dimensions. They include measurement complexity of side-effect on the one side and relative
life impact of the side-effect weighted by its incidence in the natural disease history on the other side
(see [20], Figure 2, for detailed information). Hence, complex changes represent side-effects that are
associated with a high level of measurement complexity—an indirect evidence for it being an above
average variance of the documented prevalence of a specific side-effect—and a correspondingly high
level of relative life impact for the patient but also his/her social surrounding. Unfortunately, our
own research provides evidence that the third-person perspective is almost never assessed in current
practice (the usage of test scores that emerge from persons affiliated with the patient, are basically
nonexistent [21], with the exception of some few recent studies (e.g., [22,23]). Paradigmatic examples
of complex changes include changes in personality and moral behaviour. Because there is the problem
of measurement complexity, predicting side-effects relating to psychosocial functioning of the patient
is currently difficult. Despite the fact that patients raise their concern over the propensity of DBS
to cause personality-related changes and that cases in which sudden alterations of personality after
DBS have been described (see next paragraph), less emphasis has been put on the construction of
instruments for quantifying personality-related changes. It thus stands to reason that complex changes
in general (i.e., not limited to stimulation-induced changes) are generally underreported and hence
affect the patient population to a much greater extent than assumed. The relative life-impact, in the
meanwhile, depends on not only the type of side-effect but also on factors such as, among others, the
pre-operative psychosocial status of the individual and premorbid personality traits.
As listed above, non-motor problems following DBS interventions—factors that clearly constrain
the effectiveness of this type of intervention—often comprise a neuropsychiatric dimension. While
some studies investigated non-motor problems following DBS interventions, few if any have focused
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on more demanding notions of personality and psychosocial competency [15], probably because of the
complexity of the subject matter. For example, STN-DBS has been associated with deficits on a variety
of tasks that require inhibition of prepotent responses and response selection during situations of
high conflict (for a review, see [16]; for augmented impulsivity, see [24–26]; for a study demonstrating
increased impulsivity assessed by the Barratt Impulsiveness Scale (BIS), see [27]), but few investigations
included more profound notions of personality (see next paragraph). With regard to changes in mood
and behaviour, a meta-analysis involving 1398 patients and 82 studies by Temel et al. [28] outlined that
8% suffer from depression, while activities of daily living (ADL) score improved by 52%, consistent
with other reports documenting an improvement in QoL that is only related to physical aspects but
not to mood ([29]: prospective study with non-implanted PD patients as control group). The latter
study also highlighted 9% psychiatric complications (compared to 3% in the control group). Another
more recent study found few changes in mood and behaviour with unilateral STN or GPi DBS, relating
to worsened anxiety, depression and mania [30]. Other studies also revealed an increase in QoL
including emotional well-being (for improvements of anxiety and depression see [31–33], in case of
stigma and bodily discomfort see [34,35]). Particularly, the study of Witt and colleagues [19] found an
improvement in anxiety, otherwise psychiatric adverse events in 16.7% of patients (compared to 12.7%
for best medical treatment group) and a decrease in frontal cognitive functioning with no consequences
on improvements in QoL. Finally, alterations in decision-making of PD patients measured by the
Iowa gambling task (IGT) have been demonstrated by Pagonabarraga and colleagues [36] (with
results pointing at similar decision-making deficits as seen in ventromedial prefrontal cortex (PFC)
lesioned patients and pathological gamblers). Even though incorporating only a small sample size,
Bentrup et al. [37] found an increase in “novelty seeking” in two out of 15 patients besides a decrease
of sociomoral judgment on the six-level Kohlberg scale. On the contrary, Brandt et al. found that DBS
may temper the tendency of risk-taking on risky decision making tasks with DBS patients being more
risk-averse in ambiguous-risk situations [38].
With regard to personality changes mirroring temperament and character, Houeto and
colleagues [39] have examined, in an earlier study and retrospectively, adjustment disorders (using
the social adjustment scale (SAS)), personality changes (using the Iowa rating scale of personality
change (IRSPC)) and psychiatric disorders (using psychiatric interviews and the mini international
neuropsychiatric inventory). Results indicated moderately to severely impaired social adjustment by
62.5% while personality traits were improved by 35% and aggravated by another 35%. Table 1 lists
these and the forthcoming outcomes of some recently performed DBS-studies together with a brief test
description, overall revealing that more studies and new instruments would be desirable. Another
retrospective study of the same researchers [34], however, observed very different results including
unmodified personality traits (as assessed by the Temperament and Character Inventory-revised
(TCI-R) and this contrary to [40], who found increased scores on two Novelty-Seeking subscales
of the same measure) and social adjustment apart from improved depression, anxiety and QoL.
Denheyer and colleagues [41], on the other hand, used the Frontal Systems Behavior Scale (FrSBE) in
order to assess behavioural changes including apathy, disinhibition and executive dysfunction. In a
retrospective study with a non-representative sample, all scores increased significantly. Notably, most
of the above-listed instruments have important limitations, such as, for example, the subjective nature
of the FrSBE that is influenced by e.g., preconceived expectations about the outcome of DBS. Taken
together, these outcomes imply relatively contradictory results. To be clear, psychosocial dysfunction
and changes relating to altered character after DBS, potentially resulting in difficulties of social
adjustment, satisfaction gaps and conflicting outcome interpretations between patients, their relatives
and practitioners, have vaguely been described ([42,43], or studies using e.g., the SAS), but have
not been investigated focusing on causal elements leading to such changes. Because few empirical
studies that investigate personality changes exist, recently Lewis and colleagues [22] have examined
the latter by use of semi-structured interviews and a neuropsychiatric battery (Parkinson’s disease
questionnaire-PDQ-39, Beck depression inventory (BDI-II), apathy evaluation scale (AES), state-trait
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anxiety inventory (STAI-state), self-report manic inventory (SRMI), Barratt impulsiveness scale (BIS-11),
hypomanic personality scale (HPS) and mini mental status examination (MMSE)), highlighting that
personality changes occur between 22% (self-evaluation) and 44% (evaluation by caregiver, e.g.,
spouses), with another 57% perceiving mood changes as positively, thereby emphasizing the relevance
of such investigations. However, higher apathy and anxiety levels were found in the negative change
group. The fact that the used standard measurement scales were unsuccessful in adequately reflecting
personality and mood changes in this study, substantiates the need for better and refined instruments.
One more recent study investigated personality changes after DBS [23]: the 125-item version of the TCI
(TCI-125), the urgency-premeditation-perseverance-sensation seeking (UPPS) impulsive behaviour
scale and the Eysenck Personality Questionnaire (EPQ) have been used with findings relating to
increased impulsivity and personality changes in Persistence- and Self-Transcendence test scores
(see Table 1). Notably, the previously listed non-motor problems are likely to be associated with
other fine-grained changes which may reach far into the domain of personal convictions, values and
sensitivities. These changes might be so nuanced that they will slip through current assessment of
psychiatric test batteries (for example, see [22]). Hence, even though there are a number of tests
for investigating e.g., impulsivity (e.g., Eriksen flanker and Simon task, the Stroop color word
interference task and random number generation; [16]), less emphasis has been put on the construction
of instruments for quantifying nuanced personality-related changes [5,44], including instruments
depicting personal competencies in sociomoral information processing in order to have instruments at
one’s disposal that pick up relevant topics that matter to patients and caregivers.
Addressing complex personality-related changes with the requisite rigour may explain causal
elements for the emergence of conflicting outcome interpretations and social maladjustment that are
relevant for patients and their relatives. Clearly, such instruments need to rely on newer insights of
psychological research (see Section 4.2). While in the large majority of patients, symptoms relating to
dominant expressions of behavioural phenotypes such as impulse control disorders or hypomania can
be controlled (either they vanish spontaneously or by adjusting stimulation and/or drug treatment),
more subtle changes have rarely been addressed so far due to the lack of sensitive instruments that
measure complex changes beyond standard test-psychology. Given that some behavioural changes
listed above had long-lasting social effects and damaged relationships that often only came to the
fore through in-depth qualitative research [45], and given that patients express their concern over
personality-related changes secondary to deep brain stimulation—as clinical experience at our clinic
shows—together with the magnitude of the life impact for patients and their relatives, it is staggering
that, if any, only a very limited set of data e.g., [22,23,46] and few established instruments apart from
very general personality assessment tools of standard test psychology (e.g., the big five personality
test, but see Table 1) are currently available that deal with the topic of personality-related changes.
The limited data is surprising also when considering that changes in personality and mood under DBS
in PD are discussed both in the clinical but also the ethical literature [47–50]. In addition to the problem
of measuring complex changes, there is also the evaluation difficulty relating to the problem of how
to evaluate such changes. As Kraemer [51] pointed out, “alienation from alienating conditions” can
occur. The latter denotes the difficulty of how to evaluate changes in personality. Are marital problems
following DBS implantations categorically social maladjustments or may they, in a proportion of
patients, reflect a changed personality denoting to more fundamental desires and thoughts that are at
the core of the patients’ true self? Does a given change in personality symbolize alienation or approach
to a patient’s pre-morbid personality? Without going into the details of such difficult questions, it
is enough to stress that instruments and their ability to measure complex changes are a necessary
precondition in order to move on and evaluate whether complex changes are problematic (including
e.g., notions of felt-authenticity and felt-alienation). This includes the very possibility that not all
changes are per se negative and that also positive personality changes following DBS surgery can
occur. The latter is particularly important in the context of psychiatric DBS intervention where the
positive change of ones’ personality is at the core of the therapeutic aim. These strategies may inform
ethically responsible decision making in e.g., the referral practice of DBS interventions (see Section 4.3).
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Table 1. Outline of some of the recently used measures of personality in deep brain stimulation (DBS) studies, including measurement description and study outcome
with reference numbers in brackets.
Name of Test/Scale Short-Description Study & Main Study Results
Social adjustment scale
(SAS)
Semistructured interview, performed in the presence of the spouse, that
evaluates current social adjustment in terms of 44 items
Houeto et al., 2002 [39]: moderately to severely impaired social
adjustment by 62.5%; Houeto et al., 2006 [34]: SAS global score
and subscores (work, social life and leisure activities, family life,
marital relations, and interaction with children) unmodified
Iowa rating scale of
personality change (IRSPC)
30 characteristics are assessed, ratings are gathered from family members
with regular contact with the patient
Houeto et al., 2002 [39]: personality traits were improved by
35% aggravated by 35% und unchanged by another 30%
Temperament and
Character
Inventory-revised (TCI-R)
Self-evaluation, four temperaments (Novelty Seeking (NS), Harm
Avoidance (HA), Reward Dependence (RD), Persistence (PS)) and three
characters (Self-Directedness (SD), Cooperativeness (CO),
Self-Transcendence (ST))
Fassino et al., 2010 [40]: higher scores emerged on two
Novelty-Seeking subscales; Houeto et al., 2006 [34]: unmodified
personality traits; Pham et al., 2015 (TCI-125) [23]: patients
reported lower score on the TCI Persistence and
Self-Transcendence scales, after three months of subthalamic
nucleus stimulation (STN-DBS), compared to baseline
Eysenck Personality
Questionnaire (EPQ)
Self-report questionnaire: Extraversion, Neuroticism, Psychoticism and
Lie scale
Pham et al., 2015 [23] (Neuroticism and Lie subscales (EPQ-N,
EPQ-L)): no changes
Frontal Systems Behavior
Scale (FrSBE)
Behavioral assessment of frontal lobe syndromes, includes items related to
apathy, disinhibition, and executive dysfunction; 46-item behavior rating
scale, self-evaluation and family evaluation
Denheyer et al., 2009 [41]: apathy, disinhibition and executive
dysfunction increased
X
Semi-structured interviews, developed by the ELSA-DBS study group
(a project that examines Ethical, Legal and Social Aspects of Deep Brain
Stimulation with respect to health, quality of life and personal identity) to
investigate motor, emotional, social, behavioural and cognitive
functioning, activities of daily living and QoL
Lewis et al., 2015 [22]: personality changes occurred between 22%
(self-evaluation) and 44% (evaluation by caregiver, e.g., spouses)
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In sum, we argue that there is currently a lack of valid instruments that adequately depict changes
in psychosocial processing. Even though a limited number of standardized questionnaires and tests
are available, they may not reflect sufficiently the behavioural and affective changes and their effects
in real life. Therefore, new avenues for the better description of complex personality-related changes
that may explain causal elements for the emergence of conflicting outcome interpretations, in addition
to social maladjustment that are relevant for patients and their relatives, need to involve instruments
that rely on newer insights of psychological research.
3. Psychosocial Competencies
3.1. Individual Identity, Personality and Psychosocial Competencies: Conceptualizations and Interconnections
As proposed elsewhere [5], a conceptual clarification of individual identity and personality is
decisive for evaluating and measuring potential personality-related changes in the future. Even though
the focus of this contribution is empirical rather than conceptual, a brief conceptual clarification is
necessary. While “individual identity” may be understood as a philosophical concept, “personality”
refers to a psychological one [5]. Because the latter is empirical in nature, it is part of this work.
Personality can briefly be described as the combination of certain characteristics or qualities that form
an individual’s idiosyncratic character. It is commonly defined as “the organized set of characteristics
possessed by a person that uniquely influences his or her cognitions, motivations, and behaviours in
various situations” [52]. Psychosocial competencies are one class of examples that can influence and
guide a person’s cognition, motivation and behaviour and hence align with the previous definition
of personality. They include, among others, self-regulatory skills, the ability to identify issues linked
to personal desires and values and to align one’s behaviour according to one’s self-conception, the
desire to orient oneself towards and strive for one’s ideals, skills to resolve conflicting (internal or
external) tendencies and the ability to act consistently with one’s internal thoughts and ideas. They
furthermore guide human cognition through schemas and scripts (i.e., cognitive representations,
e.g., [53,54]). Personality changes as understood in current psychology refer to alterations in the “Big
Five” personality traits (i.e., extraversion, neuroticism, agreeableness, conscientiousness, openness
to experience; see [55]), representing a very vague sum of a set of traits that can be altered.
Notably, the latter concept has recently been expanded by the HEXACO model that adds a sixth
trait circumscribing ones’ personality. That this sixth personality trait is precisely moral in nature
(honesty-humility-dimension) is certainly an interesting development that aligns with the requested
emphasis on morality and its associated competencies expressed in this contribution (see Section 4.1).
While a whole plethora of different competencies are necessary and amalgamate in interpersonal
human conduct, the time is rife for investigating basic mechanisms of psychosocial competencies and to
start developing instruments for measuring the underlying competencies. The fact that psychological
competencies are needed in situations of complex decision making and behaviour, together with
the likely potential of DBS to influence such competencies, corroborates the need of instruments to
document and evaluate changes of psychosocial functioning in order to better support patients and
their social surrounding. Moreover, DBS provides a possibility to investigate changes depending on
type of stimulation and anatomical target.
3.2. Human Behaviour as an Expression of Social Competencies
With the emergence of psychology as a scientific discipline, questions arose regarding the
identification of psychological skills that are necessary for social interaction but also regarding the
extent and interplay of biological determinants that affect psychological processes. Broadly speaking,
human behaviour includes processing external and internal stimuli and interacting with the external
world. Hence, an interactionist view is mandatory in order to explain and understand behaviour.
The same holds with regard to moral behaviour where analogously personal and environmental
or contextual factors operate interactively in determining behaviour. Personal factors include a
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specific set of competencies while environmental factors involve conditions promoting or obscuring
moral conduct (e.g., through priming by family pictures, time pressure, economic incentives, [56–59]).
In addition, moral behaviour involves a normative reference frame to which the subject has at least
partial access [60]. Thus, apart from environmental factors as well as ones’ personal moral identity,
personal competencies significantly influence human action. Because it is likely that disorders and
treatment approaches when interfering with the central nervous systems integrity directly or indirectly
alike, might influence psychosocial competencies, the investigation of abilities of patients is genuinely
pertinent. In line with this, it might be possible that DBS detrimentally influences a specific subset
of competencies in a way that facilitates the emergence of behavioural disorders, such as ICDs,
consequently leading to complex changes including e.g., psychosocial maladjustment. Unfortunately,
the potentially dysfunctional competencies secondary to DBS interventions are hardly the focus of
current research. So far, socio-moral behaviour and moral information processing following deep brain
stimulation interventions has received little attention, even though problems in social adjustment raise
questions that refer to psychosocial competences and abilities of the patient. New instruments that
are able to quantify and depict such competencies might be highly relevant because they can yield
explanatory power regarding psychosocial changes that are decisive for patients and their relatives.
4. Moral Psychological Competencies, Requirements for Instrument Implementation Strategies
and Future Use of Instruments in DBS Research and Therapy
4.1. Moral Psychological Relevance for Assessing Complex Changes in Moral Information Processing as an
Exemplary Case
The field with the richest empirical knowledge on how agents reason, decide and act morally
is still moral psychology. Undisputedly, moral behaviour in everyday situations reposes critically
on specific skills moral agents imperatively have to be equipped with. Many of those competencies
and abilities are psychological in nature. Apart from earlier approaches (see e.g., [61]) Tanner and
Christen [62] proposed an adapted framework termed “Moral Intelligence” that describes the process
logic of moral behaviour by taking into account fundamental knowledge about implicit and explicit
psychological processes and theoretical insights into morality, and superimposed on this, aiming at
translating these processes into competencies. The framework includes a content-related component
along a set of motivational, perceptive, decisional and action-related abilities. Besides that, progress in
cognitive and social neuroscience has led to investigations of other important social constructs such
as empathy and morality (see e.g., Jefferson Scale of Empathy, the multifaceted empathy test with
one study revealing reduction of the “negativity bias” in patients with treatment-resistant depression
by DBS [63], or the moral foundation scale by Haidt and the moral attentiveness scale by Reynolds).
These and other strains of research, therefore, bear witness to the importance of identifying key
competencies of human moral ability and how those competencies are rooted within and affected by
psychological processes. Because moral competencies, such as the ability to recognize ethical issues in
everyday situations, influences a person’s cognitions, motivations, and behaviours, changes in these
competencies can lead to complex, personality-related changes. Other moral-related competencies
include the possession of a more distinct desire to strive for moral goals, self-regulatory skills, the
ability to resolve conflicting tendencies or being more prone to act consistently and courageously
despite internal or external barriers. This rich variety of different skills that can be expressed in different
degrees in part account for why people act uniquely and why they display unique personalities.
4.2. Thinking Ahead: Operationalization of Moral Competencies as an Exemplary Case
As an example, one particular psychological competency that is relevant in the context of moral
behaviour is moral sensitivity (MS) [64], the ability to recognize (moral) issues in a given situation.
Being conceptualizes as the first competency in the process logic of human moral behaviour (see
Rest’s (1986) multi stage model of moral functioning [61] or the framework of Moral Intelligence [62]),
moral sensitivity is an indispensable competence to enter decision-making processes and moral
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behaviour in general. Hypothetically, it might be possible that DBS constrains the sensitivity of an
individual in such a way that makes it difficult for the patient to recognize that a given person might
be harmed by certain actions, even though he is generally of the opinion that one should abstain
from harming others. To be sure, changes in moral information processing are likely to occur also
secondary to pathological processes and (e.g., pharmacological) treatment approaches. The use of
refined instruments that depict neuropsychological competencies is, therefore, not limited to DBS.
The decreased sensitivity to recognize e.g., the harming nature of certain actions following DBS
intervention could symbolize a basis for explaining complex personality-related changes. Notably,
there is a difference between the inability to subconsciously recognize that a given value might
be harmed and the deliberate convictions somebody holds. While such fine-grained changes can
sometimes be assessed by conducting qualitative semi-structured interviews in patients [20], the
latter are often impracticable due to the time-consuming steps of post-coding. Often enough, in
times of evidence-based medicine, and hence a quantitatively oriented medical discipline, effects are
only becoming a relevant aspect of research if they can reliably be measured. Hence, quantitative
instruments should supplement qualitative research, thereby emphasizing the prima facie importance
of more vigorously investigating personality. Most importantly, and in order to safeguard clinical
meaningfulness, abstract clinical scale-improvements have to be associated with an actual improvement
in the individual patient’s life. While there were e.g., reports documenting measurable cognitive
declines, the latter were found not to be very relevant for patients’ QoL. That the same holds for
slight changes in personality is less likely, since changes in one’s personality are more probable to
have an impact on daily life by being able to endanger relationships and family life [22]. They often
affect interpersonal relations and inflict greater burden on caregivers [65], apart from the fact that
changes can be subtle so that patients themselves may be unaware of them [66]. Statistically significant
efficacy is, therefore, only a necessary, but not a sufficient condition, as it does not always correspond
to meaningful changes. QoL assessments are one way to document clinical meaningfulness, but
the construct itself is very difficult to assess (e.g., unrealistic expectations about DBS outcomes can
fundamentally influence QoL in that no improvement is seen in QoL despite motor improvement).
By aligning our own research to the mentioned need, we recently have built a computerized instrument
to measure MS by taking into account recent insights from moral psychology [67]. Needless to say,
instruments need to satisfy common psychodiagnostic standards including reliability, validity and
other quality characteristics of psychological test-theory in order to guarantee that these instruments
measure what they intend to measure and with the requisite precision.
Challenges of the instrument development process are multifaceted and include e.g., the
incorporation of vague quantifiers in the context of psychosocial functioning. The step of specifying
basic components is therefore utterly important. In addition, the delicate nature of the instruments’
content, covering morality including e.g., anti-social compulsions or sexual urges, poses implicit
challenges to instrument development and data acquisition. Besides that, there might be the problem
of overlapping functions denoting the difficulty of dissociating competencies that result in moral
action. Instruments should likewise, to some degree, adhere to the criterion of generalizability or, as a
minimum criterion, context-dependent instruments would need some form of justification. They are
also expected to refrain from provoking biased responses by e.g., avoiding including the terms
“ethical” and “moral”. In addition, instruments should take up recent insights of moral-psychological
research. Correspondingly, instruments that are entirely based on self-reports are susceptible to
bias, due to the provocation of social-desirable answer tendencies or e.g., reduced awareness based
on frontal-subcortical circuit dysfunction. Finally, the methodological requirements should be as
low as possible: because the categorization (post-coding) of issues (mentioned by participants)
is time-consuming and requires the analysis of inter-rater-reliabilities, and because some implicit
measurements impose participants to work on computers and in controlled environments, they are
unsuited for quantitative research approaches.
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In sum, in the context of neuropsychological competencies of socio-moral information processing,
even fewer instruments exist at present. Future instruments that focus on socio-moral functioning
should comply with the requirements of psychological test theory besides taking up recent insights of
(moral) psychological research.
4.3. Future Use and Advantage of Instruments Measuring Moral Competencies
Generally, the deployment of instruments that measure psychosocial functioning are conceivable
for the referral practice in DBS interventions and as diagnostic outcome-measures in order to measure
pre-post DBS effects. The prospective measurement of complex changes may help with making
predictions regarding who is likely to experience clinically significant personality-related alterations,
making individualized counselling possible, and aiming at minimizing negative impacts on patients
and their families.
Because competencies are believed to be flexible entities that evolve and change over time,
the focus on psychosocial competencies might encourage investigating means for modulating such
competencies for the better, as a potential form of therapeutic interventions. By such an approach,
subjects have the opportunity to inimitably learn more about as well as specifically train ones’
own competencies.
5. Conclusions
Whilst DBS has provided hope for a large number of patients and while a number of scales for
e.g., assessing motor changes have been developed during the last years, there is a conspicuous lack of
instruments that target and adequately depict personality-related changes specifically. Standardized
questionnaires and tests are available, but they may not reflect sufficiently the behavioural changes
and their effects in real life. Together with the highlighted lack of sensitive instruments, an
appreciation of the concrete incidence of personality-related changes (evoked by DBS or other treatment
approaches) is impossible. Therefore, there is great need for refined instruments that quantify complex,
personality-related changes at a satisfactory level. While the clinical significance of any measured
change has to be demonstrated, the frequency of such changes has to be investigated by representative
samples and prospective study designs in order to systematically investigate these changes in patients
relative to controls. Because such instruments may explain causal elements for the emergence of
conflicting outcome interpretations and social maladjustment that are relevant for patients and their
relatives, such research is desperately needed. Integrating caregivers and families’ perceptions of the
patient and the impact on their life would complement this complex investigation, thereby safeguarding
clinical meaningfulness. Given the challenge patients may face when finding a “new” personality after
being freed from the motor symptoms, and the subsequent loss of (motor) autonomy that kept them
fettered to PD, it is utterly important to give patients, their relatives and clinicians means for granting
ways for measuring and assessing changes in an appropriate way. Hence, the time is rife for advancing
DBS treatment along both the technological axis, and an axis that involves the holistic assessment
including personality in its full intricacy in order to provide further help to many patients. Besides
empirical research that includes the development of instruments and the systematic and longitudinal
investigation of complex changes that relate to personality, conceptual investigation on identity and
qualitative research with patients, their relatives and clinicians are highly relevant. It is only with the
construction of sensitive instruments, allowing a subtle measurement of the type of change, that an
evaluation of the positive or negative nature of change is possible. Finally, besides a clinical, it is also
an ethical requirement to further investigate complex changes in order to responsibly apply DBS.
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Abbreviations
The following abbreviations are used in this manuscript:
DBS Deep Brain Stimulation
PD Parkinson’s Disease
STN Subthalamic Nucleus
GPi Globus Pallidus Internus
SNr Substantia Nigra Pars Reticulata
ICD Impulse Control Disorders
OCD Obsessive Compulsive Disorder
BG Basal Ganglia
QoL Quality of Life
DDS Dopamine Dysregulation Syndrome
DAWS Dopamine Agonist Withdrawal Syndrome
ADL Activities of Daily Living
SAS Social Adjustment Scale
FrSBE Frontal Systems Behavior Scale
PDQ-39 Parkinson’s Disease Questionnaire-(PDQ-39)
BDI-II Beck Depression Inventory-II
AES Apathy Evaluation Scale
STAI-state State-Trait Anxiety Inventory
SRMI Self-Report Manic Inventory
BIS-11 Barratt Impulsiveness Scale
HPS Hypomanic Personality Scale
MMSE Mini Mental Status Examination
BIS Barratt Impulsiveness Scale
TCI-R Temperament and Character Inventory-Revised
TCI-125 125-Item Version of The Temperament and Character Inventory (Including Dimensions of
Temperament (Novelty Seeking, Harm Avoidance, Reward Dependence, Persistence) and
Character (Self-Directedness, Cooperativeness and Self-transcendence))
UPPS Impulsive Behaviour Scale
EPQIGT Eysenck Personality QuestionnaireIowa Gambling Task
IRSPC Iowa Rating Scale of Personality Change
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